Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Selenium Sulfide is an antifungal used to treat dandruff, seborrheic dermatitis of the scalp, and tinea capitis. Selenium Sulfide is an antifungal agent as well as a cytostatic agent, slowing the growth of hyperproliferative cells in seborrhea.
- Mechanism
- Curator reviewed
Topical selenium sulfide may act by an antimitotic action, resulting in a reduction in the turnover of epidermal cells. It also has local irritant, antibacterial, and mild antifungal activity, which may contribute to its effectiveness. An antimitotic mechanism of action is suggested by data showing that selenium sulfide decreases the rate of incorporation of radioactively labeled thymidine into the DNA of dermal epithelial cells. The following organisms are generally considered susceptible to selenium sulfide in vitro: Malassezia furfur, Microsporum sp. including Microsporum audouinii and Microsporum canis, Pityrosporon sp., Trichophyton sp. including Trichophyton schoenleinii and Trichophyton tonsurans. Selenium sulfide has been shown to be sporicidal to T. tonsurans, the most common etiologic agent of tinea capitis. One in-vitro study demonstrated that 2.5% selenium sulfide was equivalent in sporicidal activity to both 1% and 2% zinc pyrithione.
- Primary indication
- For treatment of tinea versicolor, tinea capitis, dandruff and seborrheic dermatitis of the scalp.Curator reviewed · 3 structured indications
- Formula / weight
- S2Se · 143.09 g/mol (avg)
- First approval
- Canada, 2002 · United States, 1952
- Also known as
- Selenium disulfide · Selenium disulphide · Selenium sulphide · Selenium(IV) disulfide · Selenium(IV) disulphide
- Brand names
- Selrx
- Selsun Blue
Resolves to
JNMWHTHYDQTDQZ-UHFFFAOYSA-NSMILESS=[Se]=SWhat you can answer from here — as of September 23, 2026
Which other approved drugs treat the same conditions as Selenium Sulfide, and which companies have late-stage candidates in those indications?